Literature DB >> 1400978

Optimum use of selective plated media in primary processing of respiratory tract specimens from patients with cystic fibrosis.

G V Doern1, B Brogden-Torres.   

Abstract

A total of 258 respiratory tract specimens from patients with cystic fibrosis were inoculated onto nine different plated media, and the rates of recovery of potential pathogens were compared. Media included sheep blood agar, enriched chocolate agar, MacConkey agar for gram-negative bacilli, chocolate agar containing bacitracin for Haemophilus spp., bromcresol green agar for yeasts, cetrimide agar for Pseudomonas spp., sheep blood agar containing colistin and nalidixic acid for gram-positive cocci, mannitol salt agar for Staphylococcus aureus, and oxidation-fermentation agar containing 300 U of polymyxin B per ml and 2 U of bacitracin per ml (OF-PBL medium) for Pseudomonas cepacia. With two exceptions, all of these media proved useful in recovering potential pathogens from respiratory tract specimens from patients with cystic fibrosis. The two exceptions were cetrimide agar and colistin-nalidixic acid-supplemented sheep blood agar, which were found to be superfluous. In addition, the results of this study further delineated the prevalence of selected bacteria and fungi in respiratory tract secretions from patients with cystic fibrosis. In rank order of frequency of isolation, we recovered isolates of Pseudomonas aeruginosa, Haemophilus parainfluenzae, Candida albicans, S. aureus, Haemophilus influenzae, molds, members of the family Enterobacteriaceae, yeasts other than Candida albicans, miscellaneous gram-negative bacilli, beta-hemolytic streptococci, P. cepacia, and Streptococcus pneumoniae.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1400978      PMCID: PMC270512          DOI: 10.1128/jcm.30.10.2740-2742.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  Facilitated detection of antibiotic-resistant Pseudomonas in cystic fibrosis sputum using homogenized specimens and antibiotic-containing media.

Authors:  M Maduri-Traczewski; C L'Heureux; L Escalona; A Macone; D Goldmann
Journal:  Diagn Microbiol Infect Dis       Date:  1986-11       Impact factor: 2.803

2.  Selective media for the quantitation of bacteria in cystic fibrosis sputum.

Authors:  K Wong; M C Roberts; L Owens; M Fife; A L Smith
Journal:  J Med Microbiol       Date:  1984-04       Impact factor: 2.472

3.  Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis.

Authors:  P H Gilligan; P A Gage; L M Bradshaw; D V Schidlow; B T DeCicco
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

4.  Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis.

Authors:  D F Welch; M J Muszynski; C H Pai; M J Marcon; M M Hribar; P H Gilligan; J M Matsen; P A Ahlin; B C Hilman; S A Chartrand
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

5.  Comparative evaluation of selective media for isolation of Pseudomonas cepacia from cystic fibrosis patients and environmental sources.

Authors:  L A Carson; O C Tablan; L B Cusick; W R Jarvis; M S Favero; L A Bland
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

6.  Effect of N-acetylcysteine on antibiotic activity and bacterial growth in vitro.

Authors:  M F Parry; H C Neu
Journal:  J Clin Microbiol       Date:  1977-01       Impact factor: 5.948

7.  Selective media for recovery of Haemophilus influenzae from specimens contaminated with upper respiratory tract microbial flora.

Authors:  K C Chapin; G V Doern
Journal:  J Clin Microbiol       Date:  1983-06       Impact factor: 5.948

8.  Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis.

Authors:  P H Gilligan; P A Gage; D F Welch; M J Muszynski; K R Wait
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

9.  Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis.

Authors:  O C Tablan; L A Carson; L B Cusick; L A Bland; W J Martone; W R Jarvis
Journal:  J Clin Microbiol       Date:  1987-03       Impact factor: 5.948

10.  Bacteriology of sputum in cystic fibrosis: evaluation of dithiothreitol as a mucolytic agent.

Authors:  M R Hammerschlag; L Harding; A Macone; A L Smith; D A Goldmann
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

View more
  11 in total

1.  Cohort Study of Airway Mycobiome in Adult Cystic Fibrosis Patients: Differences in Community Structure between Fungi and Bacteria Reveal Predominance of Transient Fungal Elements.

Authors:  Rolf Kramer; Annette Sauer-Heilborn; Tobias Welte; Carlos A Guzman; Wolf-Rainer Abraham; Manfred G Höfle
Journal:  J Clin Microbiol       Date:  2015-07-01       Impact factor: 5.948

2.  N-acetyl-D-glucosamine medium improves recovery of Haemophilus influenzae from sputa of patients with cystic fibrosis.

Authors:  L V Möller; L van Alphen; H Grasselier; J Dankert
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

3.  Impact of microbiology practice on cumulative prevalence of respiratory tract bacteria in patients with cystic fibrosis.

Authors:  M R Shreve; S Butler; H J Kaplowitz; H R Rabin; D Stokes; M Light; W E Regelmann
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

4.  Nutritional physiology and selective isolation of Exophiala dermatitidis.

Authors:  G S de Hoog; G Haase
Journal:  Antonie Van Leeuwenhoek       Date:  1993       Impact factor: 2.271

5.  Th2 allergic immune response to inhaled fungal antigens is modulated by TLR-4-independent bacterial products.

Authors:  Jenna B Allard; Lisa Rinaldi; Matthew J Wargo; Gilman Allen; Shizuo Akira; Satoshi Uematsu; Matthew E Poynter; Deborah A Hogan; Mercedes Rincon; Laurie A Whittaker
Journal:  Eur J Immunol       Date:  2009-03       Impact factor: 5.532

6.  Comparison of three methods for culturing throat swabs from cystic fibrosis patients.

Authors:  J E Hoppe; U Theurer-Mainka; M Stern
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

7.  Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis.

Authors:  Sven D Willger; Sharon L Grim; Emily L Dolben; Anna Shipunova; Thomas H Hampton; Hilary G Morrison; Laura M Filkins; George A O'Toole; Lisa A Moulton; Alix Ashare; Mitchell L Sogin; Deborah A Hogan
Journal:  Microbiome       Date:  2014-11-03       Impact factor: 14.650

8.  Emergence of respiratory Streptococcus agalactiae isolates in cystic fibrosis patients.

Authors:  Vera Eickel; Barbara Kahl; Beatrice Reinisch; Angelika Dübbers; Peter Küster; Claudia Brandt; Barbara Spellerberg
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

9.  Clinical implications and characterization of Group A Streptoccoccus infections in adults with cystic fibrosis.

Authors:  Kate Skolnik; Austin Nguyen; Ranjani Somayaji; Christina S Thornton; Barbara Waddell; Michael G Surette; Harvey R Rabin; Michael D Parkins
Journal:  BMC Pulm Med       Date:  2015-12-12       Impact factor: 3.317

10.  Group B streptococcus (GBS) is an important pathogen in human disease- but what about in cystic fibrosis?

Authors:  Kate Skolnik; Austin Nguyen; Christina S Thornton; Barbara Waddell; Tyler Williamson; Harvey R Rabin; Michael D Parkins
Journal:  BMC Infect Dis       Date:  2017-10-02       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.